US pharmaceutical company Merck & Co. announced it is to build an R&D headquarters in Beijing, China on 6 December.
The facility is part of a commitment the company has made in China over the next five years of $1.5 billion.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.